Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy.
Saved in:
| Title: | Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy. |
|---|---|
| Authors: | Karkempetzaki, Anastasia Iris1,2,3 (AUTHOR), Schatton, Tobias1,2,4 (AUTHOR) tschatton@bwh.harvard.edu, Barthel, Steven R.1,2,3 (AUTHOR) sbarthel@bwh.harvard.edu |
| Source: | International Journal of Molecular Sciences. Aug2025, Vol. 26 Issue 16, p7998. 38p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms26167998 |